Fig. 3
From: Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation
Immunofluorescence for SOX2 in GBM (Alexa Green 488) and total cells (NucBlue). In the top panels A–C, SOX2 is present in a high percentage of cells and more uniformly distributed within the field (and between fields), than in a low-expressing case (bottom panels, D-F), where the percent of SOX2 + cells is lower and varies more across an individual field and between fields. (A, D – Alexa Green 488, B, E –NucBlue, C, F – Overlay)